Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Adamis Pharmaceuticl (ADMP)

Adamis Pharmaceuticl (ADMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,254
  • Shares Outstanding, K 9,359
  • Annual Sales, $ 4,760 K
  • Annual Income, $ -26,480 K
  • EBIT $ -27 M
  • EBITDA $ -25 M
  • 60-Month Beta 1.27
  • Price/Sales 1.51
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.09
  • Most Recent Earnings $-2.79 on 08/21/23
  • Next Earnings Date 08/23/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +3.35%
on 09/07/23
1.4300 -45.80%
on 08/08/23
-0.5849 (-43.01%)
since 08/07/23
3-Month
0.7500 +3.35%
on 09/07/23
8.2800 -90.64%
on 08/01/23
-1.3849 (-64.12%)
since 06/07/23
52-Week
0.7500 +3.35%
on 09/07/23
26.1800 -97.04%
on 09/20/22
-21.9749 (-96.59%)
since 09/07/22

Most Recent Stories

More News
Adamis: Q2 Earnings Snapshot

Adamis: Q2 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
Adamis: Q1 Earnings Snapshot

Adamis: Q1 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
ADAMIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adamis Pharmaceuticals Corporation - ADMP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”)...

ADMP : 0.7751 (+0.86%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Adamis Pharmaceuticals Corp. - ADMP

/PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national...

ADMP : 0.7751 (+0.86%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ROCC, BTE, ADMP, VBLT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ROCC : 37.47 (-1.96%)
BTE : 2.41 (+1.26%)
ADMP : 0.7751 (+0.86%)
VBLT : 5.4600 (-8.77%)
ADMP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Adamis Pharmaceuticals Corporation Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) and DMK Pharmaceuticals, Corp. is fair to Adamis shareholders.

ADMP : 0.7751 (+0.86%)
Stocks Mixed Before The Open As Fed Fears Persist, Target Earnings On Tap

March S&P 500 futures (ESH23) are trending up +0.07% this morning after three major U.S. benchmark indices ended the regular session higher as investors digested an early round of U.S. economic data and...

ESH23 : 3,957.05s (-0.09%)
TSLA : 462.28 (+7.36%)
SGEN : 228.74 (-0.07%)
UNP : 229.75 (+1.15%)
ZM : 85.67 (+0.47%)
WDAY : 269.04 (+1.38%)
TGT : 132.40 (+0.36%)
MNST : 52.51 (+1.25%)
HPQ : 33.44 (+0.63%)
RIVN : 14.06 (+2.25%)
NCLH : 26.42 (+1.11%)
BAYN.D.DX : 18.866 (-0.32%)
Adamis: Q3 Earnings Snapshot

Adamis: Q3 Earnings Snapshot

ADMP : 0.7751 (+0.86%)
Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 1:30 p.m. PT / 4:30 p.m. ...

ADMP : 0.7751 (+0.86%)
Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and...

ADMP : 0.7751 (+0.86%)

Business Summary

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned...

See More

Key Turning Points

3rd Resistance Point 0.8332
2nd Resistance Point 0.8116
1st Resistance Point 0.7933
Last Price 0.7751
1st Support Level 0.7534
2nd Support Level 0.7318
3rd Support Level 0.7135

See More

52-Week High 26.1800
Fibonacci 61.8% 16.4657
Fibonacci 50% 13.4650
Fibonacci 38.2% 10.4643
Last Price 0.7751
52-Week Low 0.7500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar